Infant Bacterial Therapeutics AB (publ) (STO:IBT.B)

STO:IBT.B Revenue

Infant Bacterial Therapeutics AB had revenue of -1.00K SEK in the twelve months ending June 30, 2025, down -101.45% year-over-year. In the year 2024, Infant Bacterial Therapeutics AB had annual revenue of 4.00K, down -94.81%.

• Revenue (ttm): -1.00K
• Revenue Growth: -101.45%
• P/S Ratio: -913,362.28
• Revenue / Employee: -125.00
• Employees: 8
• Market Cap: 913.36M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	4.00K	-73.00K	-94.81%
Dec 31, 2023	77.00K	65.00K	541.67%
Dec 31, 2022	12.00K	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-